Ultragenyx Pharmaceutical Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 10.13 M | $304.79 M | -0.79% | 10.29% |
| FMR LLC | 11/13/2025 | 7.28 M | $219.08 M | 179.63% | 7.40% |
| BLACKROCK, INC. | 11/12/2025 | 6.43 M | $193.27 M | 2.70% | 6.53% |
| JPMORGAN CHASE & CO | 11/26/2025 | 4.01 M | $120.66 M | 23.02% | 4.07% |
| SANDS CAPITAL MANAGEMENT, LLC | 11/13/2025 | 3.77 M | $113.40 M | -4.40% | 3.83% |
| STATE STREET CORP | 11/14/2025 | 3.69 M | $111.07 M | 43.55% | 3.75% |
| RTW INVESTMENTS, LP | 11/14/2025 | 3.26 M | $98.01 M | 90.83% | 3.31% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 2.77 M | $83.40 M | 0.00% | 2.82% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 2.31 M | $69.49 M | -19.96% | 2.35% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 2.17 M | $65.21 M | 614.09% | 2.20% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 2.02 M | $60.73 M | -11.37% | 2.05% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 1.95 M | $58.51 M | 3.92% | 1.98% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.58 M | $47.55 M | -7.73% | 1.61% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.55 M | $46.51 M | -7.19% | 1.57% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 1.55 M | $46.48 M | 6.41% | 1.57% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.46 M | $43.99 M | -14.22% | 1.48% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 1.25 M | $37.49 M | -10.40% | 1.27% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/12/2025 | 1.15 M | $34.60 M | 138.98% | 1.17% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 1.14 M | $34.43 M | 101.81% | 1.16% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 11/14/2025 | 1.07 M | $32.16 M | 103.46% | 1.09% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 983.72 K | $29.59 M | 0.00% | 1.00% |
| ABRDN PLC | 11/07/2025 | 973.66 K | $29.29 M | 94.32% | 0.99% |
| MORGAN STANLEY | 11/14/2025 | 910.18 K | $27.38 M | 42.47% | 0.92% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 840.45 K | $25.28 M | 599.24% | 0.85% |
| INVESCO LTD. | 11/13/2025 | 794.85 K | $23.91 M | 9.77% | 0.81% |
| CANDRIAM S.C.A. | 11/06/2025 | 754.71 K | $22.70 M | 43.41% | 0.77% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 750.00 K | $22.56 M | 100.00% | 0.76% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 746.18 K | $22.45 M | 195.71% | 0.76% |
| EAGLE HEALTH INVESTMENTS LP | 11/07/2025 | 697.00 K | $20.97 M | 11.06% | 0.71% |
| NUVEEN, LLC | 11/12/2025 | 682.14 K | $20.52 M | 35.04% | 0.69% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 677.18 K | $20.37 M | 42.52% | 0.69% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 655.02 K | $19.70 M | 2.72% | 0.67% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 603.40 K | $18.15 M | -0.50% | 0.61% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 600.16 K | $18.05 M | -2.57% | 0.61% |
| BRAIDWELL LP | 11/14/2025 | 588.70 K | $17.71 M | 100.00% | 0.60% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 583.71 K | $17.56 M | 5.86% | 0.59% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 573.02 K | $17.24 M | 153.74% | 0.58% |
| UBS GROUP AG | 11/13/2025 | 547.03 K | $16.45 M | 24.20% | 0.56% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 537.50 K | $16.17 M | -44.96% | 0.55% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 532.00 K | $16.00 M | -62.78% | 0.54% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 517.70 K | $15.57 M | -39.83% | 0.53% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10/29/2025 | 501.16 K | $15.07 M | 2.99% | 0.51% |
| NORTHERN TRUST CORP | 11/14/2025 | 499.23 K | $15.02 M | 1.17% | 0.51% |
| FEDERATED HERMES, INC. | 11/03/2025 | 496.06 K | $14.92 M | -75.80% | 0.50% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 482.58 K | $14.52 M | 100.00% | 0.49% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 476.94 K | $14.35 M | 11.96% | 0.48% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2025 | 448.72 K | $13.50 M | 4.27% | 0.46% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 430.00 K | $12.93 M | -71.89% | 0.44% |
| BARCLAYS PLC | 11/12/2025 | 425.35 K | $12.79 M | 138.14% | 0.43% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/12/2025 | 422.44 K | $12.71 M | 65.51% | 0.43% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ultragenyx Pharmaceutical Inc. institutional Ownership - FAQ's
During the previous two years, 444 institutional investors and hedge funds held shares of Ultragenyx Pharmaceutical Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 10.13 M
FMR LLC: 7.28 M
BlackRock, Inc.: 6.43 M
JPMORGAN CHASE & CO: 4.01 M
SANDS CAPITAL MANAGEMENT, LLC: 3.77 M
STATE STREET CORP: 3.69 M
96.97% of Ultragenyx Pharmaceutical Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 110.47 M shares in the last 24 months. This purchase volume represents approximately $4.11 B in transactions.